Zolpidem improves dystonia in "Lubag" or X-linked Dystonia-Parkinsonism syndrome

Neurology

Volumn 58, Issue 4, 2002, Pages 662-663

  Evidente, Virgilio Gerald H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR; ZOLPIDEM;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIARRHEA; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DYSTONIA; HUMAN; MALE; PARKINSONISM; PRIORITY JOURNAL; X LINKED DYSTONIA PARKINSONISM SYNDROME;

EID: 0037176863     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.4.662     Document Type: Article

References (7)

1. X-linked dystonia ("Lubag") presenting as pure parkinsonism: A more benign phenotype?
2. Zolpidem. An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia
3. Zolpidem in Parkinson's disease
4. Zolpidem in progressive supranuclear palsy
5. A/benzodiazepine receptor-chloride ionophore complex in a genetic model of paroxysmal dystonia: A quantitative autoradiographic analysis
6. Receptors involved in the mechanism of action of zolpidem